Bayer shares up after first trial win over Roundup Shares in Bayer rose this morning after the German agricultural and pharmaceuticals firm won its first trial over claims its Roundup weedkiller causes cancer. Business • 06 Oct 21
Bayer loses appeals case over glyphosate weedkiller Bayer lost a third appeal against US court verdicts that awarded damages to customers blaming their cancers on use of its glyphosate-based weedkillers, leaving the … Business • 10 Aug 21
Bayer sticks to $2bn provision after glyphosate ruling Bayer said today it was not increasing its $2 billion in provisions after a US judge rejected its class action plan to settle future claims … Business • 27 May 21
Bayer takes €9.25 billion writedown Bayer took impairment charges of €9.25 billion and said the costs of its settlement over claims its Roundup weedkiller causes cancer would be higher as … Business • 03 Nov 20
Bayer agrees to pay $10.9bn to settle Roundup claims Bayer has agreed to settle thousands of US lawsuits claiming that its widely-used weed killer Roundup caused cancer for as much as $10.9 billion after … Business • 24 Jun 20
Bayer makes progress in settlement talks over Roundup Bayer said today it had made progress seeking a settlement over claims its glyphosate-based Roundup weedkiller causes cancer, after Bloomberg reported the company reached a … Business • 25 May 20
Bayer more stringent in glyphosate settlement talks Bayer said the economic downturn and the need to preserve cash means it is taking a tougher stance in talks to settle claims its glyphosate-based … Business • 27 Apr 20
Number of glyphosate plaintiffs jumps to 42,700 - Bayer Bayer said the number of US plaintiffs blaming its glyphosate-based weedkillers for their cancer mushroomed to 42,700 from 18,400 in July, raising the stakes in … Business • 30 Oct 19
US judge slashes Roundup jury award to $25.3m A federal judge has cut a damages award Bayer owed a California man who blamed Roundup weed killer for his cancer, to $25.27m from $80.27m. Business • 16 Jul 19
Bayer to invest €5 billion in new weedkillers Bayer, the German crop science and chemicals group reeling from US litigation over claims its glyphosate pesticide causes cancer, said it would invest €5 billion … Business • 14 Jun 19
Bayer stock falls on $2 billion award in Roundup trial Shares in Bayer were down 5.9% today after a jury awarded more than $2 billion to a California couple in the largest US jury verdict … Business • 14 May 19
Five things to know about Bayer and Monsanto The second cancer victim in a year to win a surprise victory against US pesticide maker Monsanto raises the prospect of a flood of similar … Business • 20 Mar 19
Investors flee Bayer after second Roundup trial blow The threat to German chemical giant Bayer and subsidiary Monsanto from US litigation swelled today, when its share price plunged after a jury ruled weedkiller … Business • 20 Mar 19
Bayer shares plunge 14% after Roundup cancer trial Shares in Bayer have plunged more than 14% to their lowest in almost five years - wiping around $14 billion off the value of the … Business • 13 Aug 18
Pharma giant insists weedkiller is safe despite ruling The owner of one of the most popular weedkillers on the Irish market has dismissed claims that one of its key ingredients can cause cancer … News • 11 Aug 18
